Figure 1.
Kaplan−Meier curves for the primary cardiovascular disease (CVD) outcome in Systolic Blood Pressure Intervention Trial (SPRINT) for African American participants by treatment group and APOL1 risk genotype.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.